Table 1.
Patient Demographics, Filler Details, and Indication for Dissolving Filler
| Patient and Filler Characteristics | |
|---|---|
| Proportion of females | 90% (81/90) |
| Age at presentation (y) | Mean 46 (median 45; range 22–79) |
| Volume of filler (mL) | Mean 2.1 (median 1.5; range 0.2–10) |
| Duration of filler in situ (mo) | Mean 30 (median 12; range 0–156) |
| Filler Brand | |
| Juvederm | 36% (56/157) |
| Teosyal Redensity | 17% (26/157) |
| Restylane | 13% (20/157) |
| Unknown | 35% (55/157) |
| Filler Location | |
| Tear trough only | 62% (98/157) |
| Tear trough and cheek | 24% (37/157) |
| Periorbital area | 14% (22/157) |
| Primary Indication for Filler Dissolving | |
| Swelling | 52% (81/157) |
| Lumpiness | 20% (31/157) |
| Festoons | 6% (9/157) |
| Tyndall effect | 4% (6/157) |
| Infection | 1% (2/157) |
| Filler migration | 1% (2/157) |
| In preparation for blepharoplasty surgery | 17% (26/157) |